 we propose to: (1) study their relationship to the activity and vascular complications in RA and SLE, (2) analyze those features, such as complement fixing ability, that could account for their phlogogenic capacity, (3) determine their ability to influence lymphocyte function (especially lymphocyte-mediated cytotoxicity) and, finally
we propose to: (1) study their relationship to the activity and vascular complication in RA and SLE, (2) analyze those feature, such as complement fixing ability, that could account for their phlogogenic capacity, (3) decide their ability to influence lymphocyte function (specially lymphocyte - mediate cytotoxicity) and, finally
 we propose to: (1) study their relationship to the artivity and vaszular complications in RA anv SLW, (2) anqlyze those features, sjch as colplement fixmng ability, that could ageount nor tkemr phlogogenic gapacity, (3) datermine their acipity to influence lymphocyte functijn (espeviwlly lymphocytg-mediseed djtitoxicity) and, finally
we propose to: (1) study their relationship activity vascular complications RA and SLE, as fixing ability, that account for their capacity, (3) determine their ability to lymphocyte function (especially lymphocyte-mediated cytotoxicity) and, finally
 we propose to: (1) study their relaTionship to The acTivIty AnD vasCulaR complications IN RA aNd SLE, (2) analyze those featuRes, suCh AS comPLeMent fIxing abILiTY, ThaT cOuLd aCcOUnT for tHeiR phlogoGenic capacIty, (3) DeTermine their ABiLity to inflUenCe lymphocyte FunCtion (eSpEciALly lyMphOcyte-MediatED cytotOxicity) anD, fINally
 we propose to: (1) studytheir rela tions hip  to  t he a ctiv ity and vascul a r co mplications in RA andSLE,(2 )  ana l yz e tho se feat u re s ,  su ch  a s c om p le mentfix ing abi lity, that  co ul d account fo r  t heir phlog oge nic capacity , ( 3) det er min e  thei r a bilit y to i n fluenc e lymphoc yt e  funct i on (esp e c ia llylymphocyte-mediat e dc ytotoxicity) a nd, fi na l ly 
 we_propose to:_(1) study their relationship_to the_activity_and vascular_complications_in RA and_SLE, (2) analyze_those features, such as_complement fixing ability,_that_could account for their phlogogenic capacity, (3) determine their ability to influence lymphocyte function_(especially_lymphocyte-mediated cytotoxicity)_and,_finally